Making Rational Treatment Decisions in IBD

Join Dr. Christopher Ma, an academic gastroenterologist at the Cumming School of Medicine, University of Calgary. He completed advanced clinical fellowships in inflammatory bowel disease at the University of Calgary and Western University, as well as formalized research training in clinical trial methods as the 2018 Robarts International IBD Clinical Trials fellow. He received his MPH in Epidemiology & Biostatistics from the Harvard T.H. Chan School of Public Health in 2019. His research portfolio now focuses primarily on clinical trial design and analytic methods, and the epidemiology and treatment of gastrointestinal diseases. Dr. Ma has published over 180 peer-reviewed manuscripts (h-index 35, i-10 index 90). He is the lead for the international COREOS and CORE-IBD Consortia, and has been awarded over $6.5 million in peer-reviewed research funding, including from the Canadian Institutes of Health Research, the Canadian Association of Gastroenterology, the Canadian IBD Research Consortium, and the Helmsley Charitable Trust.

This symposium will be presented prior to the start of the ADDS program on Friday, May 31 from 11:00 - 12:00pm.

Presented by: 

Clinical Data Updates on Subcutaneous Infliximab (CT-P13 SC) in IBD

Join Dr. Bincy Abraham, who earned her undergraduate degree in bioengineering at Texas A&M University in College Station, and then received her medical degree from the University of Texas Medical Branch (UTMB) in Galveston. She completed her internal medicine internship and residency, as well as a gastroenterology fellowship at UTMB, where she also earned a master’s in clinical investigation and received specialized training in inflammatory bowel disease (IBD). During her training, she completed a National Visiting Fellow IBD Rotation Program through the Crohn’s and Colitis Foundation of America at Cedars-Sinai Medical Center in Los Angeles, California. She is board certified in Internal medicine and Gastroenterology. Dr. Abraham is a member of the American Gastroenterological Association, American College of Gastroenterology, Crohn’s and Colitis Foundation, American Society of Gastrointestinal Endoscopy, and chair of the South Texas Chapter of the Crohn’s and Colitis Foundation Medical Advisory Committee.

This symposium will be presented prior to the start of the ADDS program on Sunday, June 2 from 7:30 - 8:30am.

Presented by: